2014 Fiscal Year Final Research Report
Therapeutic potential of the molecular targeting of PRL-3 and K-ras gene in colorectal cancer.
Project/Area Number |
24591982
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Digestive surgery
|
Research Institution | Kitasato University |
Principal Investigator |
|
Project Period (FY) |
2012-04-01 – 2015-03-31
|
Keywords | PRL-3 / K-ras / 大腸癌 / 予後 / リンパ節転移 |
Outline of Final Research Achievements |
(1) K-ras gene mutation was not correlated with staging factors in primary colorectal cancer, and it was recognized in about 40% of either primary or metastatic tumors. (2) Clinicopathological analysis was performed for PRL-3 genomic amplification in 100 primary tumors of colorectal cancer, and 44 metastatic liver tumors of colorectal cancer. PRL-3 genomic amplification is more frequently recognized in poorly differentiated colorectal cancer, and cases with PRL-3 genomic amplification showed poorer prognosis than those without it. (3) PRL-3 genomic amplification was significantly more frequently found in liver tumor of colorectal cancer than in the corresponding primary colorectal cancer.
|
Free Research Field |
大腸外科
|